Samar Basu Selected Research

Dinoprost

1/2015	Prostaglandin F2α formation is associated with mortality in a Swedish community-based cohort of older males.
6/2009	Low dietary intake of beta-carotene, alpha-tocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort.
1/2009	Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study.
7/2007	Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation.
1/2007	Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease.
7/2005	Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men.
4/2004	Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
1/2004	Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samar Basu Research Topics

Disease

62	Inflammation (Inflammations) 11/2017 - 01/2002
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 10/2002
11	Insulin Resistance 01/2013 - 10/2002
9	Neoplasms (Cancer) 10/2016 - 06/2003
8	Heart Arrest (Cardiac Arrest) 03/2015 - 03/2003
8	Atherosclerosis 11/2010 - 12/2002
6	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2012
5	Obesity 01/2013 - 04/2004
5	Hypertension (High Blood Pressure) 01/2012 - 07/2005
5	Overweight 12/2011 - 02/2008
5	Ischemia 05/2011 - 02/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2013 - 04/2004
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 12/2005
3	Body Weight (Weight, Body) 03/2015 - 10/2009
3	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 01/2007
3	Ventricular Fibrillation 07/2011 - 03/2003
3	Shock 08/2010 - 01/2006
3	Stroke (Strokes) 03/2009 - 03/2002
3	Reperfusion Injury 10/2007 - 07/2004
2	Lung Injury 11/2017 - 11/2002
2	Asthma (Bronchial Asthma) 11/2010 - 01/2009
2	Septic Shock (Toxic Shock Syndrome) 11/2010 - 01/2006
2	Hyperglycemia 08/2010 - 10/2002
2	Dementia (Dementias) 01/2009 - 01/2009
2	Dyslipidemias (Dyslipidemia) 08/2008 - 10/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2006 - 02/2006
1	Pneumonia (Pneumonitis) 11/2017

Drug/Important Bio-Agent (IBA)

24	C-Reactive ProteinIBA 12/2015 - 10/2002
22	Biomarkers (Surrogate Marker)IBA 10/2016 - 01/2002
19	ProstaglandinsIBA 11/2017 - 01/2002
13	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2015 - 07/2003
13	IsoprostanesIBA 01/2013 - 01/2002
13	Interleukin-6 (Interleukin 6)IBA 09/2012 - 10/2002
12	LipidsIBA 10/2016 - 10/2002
12	Prostaglandins FIBA 01/2015 - 10/2002
12	8-epi-prostaglandin F2alphaIBA 01/2007 - 10/2002
10	F2-Isoprostanes (F2 Isoprostanes)IBA 10/2016 - 10/2002
9	Free RadicalsIBA 01/2015 - 03/2003
9	CytokinesIBA 11/2013 - 04/2004
8	Glucose (Dextrose)FDA LinkGeneric 10/2016 - 06/2007
8	DinoprostIBA 01/2015 - 01/2004
8	Insulin (Novolin)FDA Link 01/2013 - 04/2004
8	Indicators and Reagents (Reagents)IBA 01/2012 - 04/2004
8	Conjugated Linoleic AcidsIBA 09/2011 - 10/2002
8	AntioxidantsIBA 05/2011 - 05/2004
8	15-keto-13,14-dihydroprostaglandin F2alpha (PGFM)IBA 07/2007 - 03/2003
7	EicosanoidsIBA 01/2013 - 03/2003
6	Fatty Acids (Saturated Fatty Acids)IBA 05/2012 - 10/2002
5	AdiponectinIBA 01/2015 - 10/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 10/2002
5	Cystatin CIBA 09/2012 - 12/2006
5	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2012 - 04/2004
4	Arachidonic Acid (Vitamin F)IBA 01/2013 - 07/2003
4	HDL CholesterolIBA 09/2011 - 05/2008
4	Triglycerides (Triacylglycerol)IBA 01/2011 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2003
3	cathepsin SIBA 12/2015 - 09/2011
3	AdipokinesIBA 01/2015 - 01/2012
3	LeptinIBA 01/2015 - 01/2012
3	Phospholipids (Phosphatides)FDA LinkGeneric 12/2011 - 05/2010
3	Trans Fatty AcidsIBA 10/2011 - 02/2006
3	Antihypertensive Agents (Antihypertensives)IBA 09/2011 - 05/2008
3	CholesterolIBA 09/2011 - 12/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2011 - 11/2006
3	Tocopherols (Tocopherol)IBA 12/2010 - 09/2004
3	Blood Glucose (Blood Sugar)IBA 08/2010 - 02/2003
3	alpha-Tocopherol FDA Link 06/2009 - 04/2004
3	oxidized low density lipoproteinIBA 12/2006 - 12/2002
3	Troponin T (Troponin T1)IBA 10/2006 - 05/2004
2	Aromatase (CYP19)IBA 01/2015 - 01/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014 - 12/2009
2	AntibodiesIBA 11/2013 - 12/2002
2	Oxygen (Dioxygen)IBA 11/2013 - 03/2008
2	SmokeIBA 07/2013 - 10/2006
2	NF-kappa B (NF-kB)IBA 01/2013 - 06/2003
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2012 - 08/2005
2	LDL CholesterolIBA 09/2011 - 12/2006
2	phospholipid emulsion soybean oil (Intralipid)IBA 05/2011 - 12/2009
2	Fish OilsIBA 01/2011 - 12/2009
2	InterleukinsIBA 01/2011 - 06/2005
2	Troponin IIBA 08/2010 - 05/2008
2	beta Carotene (Betacarotene)FDA Link 06/2009 - 07/2005
2	gamma-TocopherolIBA 01/2009 - 09/2004
2	AlbuminsIBA 09/2008 - 07/2007
2	EndotoxinsIBA 03/2008 - 01/2006
2	Methylene Blue (Methylthioninium Chloride)FDA Link 10/2007 - 11/2006
2	SolutionsIBA 10/2007 - 11/2006
2	ApolipoproteinsIBA 12/2006 - 03/2002
2	CreatinineIBA 05/2006 - 01/2002
2	AntithrombinsIBA 07/2004 - 11/2003
2	Vitamin E FDA LinkGeneric 05/2004 - 10/2002
1	OzoneIBA 11/2017
1	Oxidants (Oxidizing Agents)IBA 11/2017
1	PTX3 proteinIBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	CathepsinsIBA 12/2015
1	Cathepsin BIBA 12/2015

Therapy/Procedure

9	Cardiopulmonary Resuscitation (CPR) 03/2015 - 03/2003
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2013 - 10/2006